Earl W. May

1.8k total citations
16 papers, 511 citations indexed

About

Earl W. May is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Earl W. May has authored 16 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Earl W. May's work include DNA Repair Mechanisms (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Signaling Pathways in Disease (3 papers). Earl W. May is often cited by papers focused on DNA Repair Mechanisms (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Signaling Pathways in Disease (3 papers). Earl W. May collaborates with scholars based in United States, Germany and United Kingdom. Earl W. May's co-authors include Nancy L. Craig, Ying Li, Fred Dyda, Alison B. Hickman, Robert A. Copeland, Richard R. Gontarek, Kang Yan, John M. Berge, Eric Hunt and Erik Schaefer and has published in prestigious journals such as Science, The EMBO Journal and Molecular Cell.

In The Last Decade

Earl W. May

15 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Earl W. May United States	11	415	119	97	78	51	16	511
Andreas Christmann Germany	13	523 1.3×	72 0.6×	51 0.5×	106 1.4×	52 1.0×	18	672
Andrew C. Kile United States	11	600 1.4×	155 1.3×	50 0.5×	24 0.3×	129 2.5×	13	679
Nikolas Gunkel Germany	18	471 1.1×	45 0.4×	33 0.3×	33 0.4×	107 2.1×	25	769
Bruce A. Maguire United States	11	468 1.1×	140 1.2×	42 0.4×	74 0.9×	42 0.8×	24	618
Don Lorimer United States	10	336 0.8×	59 0.5×	65 0.7×	95 1.2×	52 1.0×	12	515
Agnès M. Jaulent United Kingdom	12	397 1.0×	35 0.3×	40 0.4×	22 0.3×	67 1.3×	15	539
Lawrence A. Loeb United States	10	537 1.3×	117 1.0×	71 0.7×	37 0.5×	88 1.7×	10	724
Dileep Vasudevan India	12	758 1.8×	38 0.3×	102 1.1×	28 0.4×	68 1.3×	30	911
Sohail A. Qureshi Pakistan	14	525 1.3×	218 1.8×	31 0.3×	80 1.0×	27 0.5×	25	668
С. А. Суржиков Russia	12	275 0.7×	51 0.4×	100 1.0×	21 0.3×	22 0.4×	60	446

Countries citing papers authored by Earl W. May

Since Specialization

Citations

This map shows the geographic impact of Earl W. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl W. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl W. May more than expected).

Fields of papers citing papers by Earl W. May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Earl W. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl W. May. The network helps show where Earl W. May may publish in the future.

Co-authorship network of co-authors of Earl W. May

This figure shows the co-authorship network connecting the top 25 collaborators of Earl W. May. A scholar is included among the top collaborators of Earl W. May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Earl W. May. Earl W. May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Tameire, Feven, Crissy Dudgeon, Kathryn Bieging-Rolett, et al.. (2025). In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation. Molecular Cancer Therapeutics. 25(1). 71–83.

Beyett, Tyler S., Earl W. May, Erik Schaefer, et al.. (2024). Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors. Communications Chemistry. 7(1). 38–38. 10 indexed citations

Laufer, Stefan, et al.. (2023). Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors. Journal of Medicinal Chemistry. 67(1). 2–16. 14 indexed citations

Heppner, David E., Tyler S. Beyett, Bo Yang, et al.. (2022). Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448). ACS Medicinal Chemistry Letters. 13(12). 1856–1863. 30 indexed citations

Yuzhakov, A. A., Cindy Benod, Linlong Xue, et al.. (2020). Abstract A06: Biophysical and biochemical characterization of KRAS G12C inhibition through the SMARTTM platform. Molecular Cancer Research. 18(5_Supplement). A06–A06. 1 indexed citations

Wanner, Jutta, Darlene Romashko, Earl W. May, et al.. (2015). Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines. PLoS ONE. 10(4). e0121793–e0121793. 13 indexed citations

Hornberger, Keith R., Xin Chen, Andrew P. Crew, et al.. (2013). Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 23(16). 4511–4516. 23 indexed citations

Jin, Meizhong, Kam Siu, Earl W. May, et al.. (2013). Discovery of Novel Insulin-Like Growth Factor-1 Receptor Inhibitors with Unique Time-Dependent Binding Kinetics. ACS Medicinal Chemistry Letters. 4(7). 627–631. 14 indexed citations

Rominger, Cynthia M., Michael D. Schaber, Jingsong Yang, et al.. (2007). An intrinsic ATPase activity of phospho-MEK-1 uncoupled from downstream ERK phosphorylation. Archives of Biochemistry and Biophysics. 464(1). 130–137. 21 indexed citations

10.

Yan, Kang, Eric Hunt, John M. Berge, et al.. (2005). Fluorescence Polarization Method To Characterize Macrolide-Ribosome Interactions. Antimicrobial Agents and Chemotherapy. 49(8). 3367–3372. 36 indexed citations

11.

Gul, Sheraz, Richard C. D. Brown, Earl W. May, et al.. (2004). Staphylococcus aureus DNA ligase: characterization of its kinetics of catalysis and development of a high-throughput screening compatible chemiluminescent hybridization protection assay. Biochemical Journal. 383(3). 551–559. 8 indexed citations

12.

Hickman, Alison B., et al.. (2000). Unexpected Structural Diversity in DNA Recombination. Molecular Cell. 5(6). 1025–1034. 97 indexed citations

13.

May, Earl W. & Nancy L. Craig. (1996). Switching from Cut-and-Paste to Replicative Tn7 Transposition. Science. 272(5260). 401–404. 104 indexed citations

14.

May, Earl W., et al.. (1996). The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products.. The EMBO Journal. 15(22). 6348–6361. 125 indexed citations

15.

May, Earl W.. (1995). A functional analysis of the inverted repeat of the gamma delta transposable element.. Journal of Molecular Biology. 247(4). 578–587. 7 indexed citations

16.

May, Earl W. & Nigel D. F. Grindley. (1995). A functional analysis of the inverted repeat of the γδ transposable element. Journal of Molecular Biology. 247(4). 578–587. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact